Studies in lung transplantation in 2008 extended many of the advances made during the previous year (1). A summary of trends in adult lung transplantation was provided by the Twenty-fifth Official Report from the International Society for Heart and Lung Transplantation (ISHLT) registry (2). The number of lung transplantations, which has steadily increased since the beginning of this decade, demonstrated stabilization near its peak. Some notable observations in the past year included a new high in both average donor and recipient age and a continuing increase in the proportion of bilateral lung transplantation. Although chronic obstructive pulmonary disease/emphysema (COPD) is still the major indication for lung transplantation, idiopathic pulmonary fibrosis (IPF) now accounts for 26% of pretransplant diagnoses. Benchmark survival rates were reported as 78% at 1 year, 63% at 3 years, 51% at 5 years, and 28% at 10 years. The survival half-life continues to be approximately 5 years, and no significant change was noted in the reported half-life of 7.3 years among 1-year survivors.